Swiss National Bank’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-100,300
| Closed | -$3.85M | – | 2637 |
|
|
2023
Q2 | $3.85M | Buy |
100,300
+10,600
| +12% | +$272K | ﹤0.01% | 1466 |
|
|
2023
Q1 | $2.08M | Sell |
89,700
-9,000
| -9% | -$215K | ﹤0.01% | 1820 |
|
|
2022
Q4 | $2.59M | Buy |
98,700
+5,200
| +6% | +$115K | ﹤0.01% | 1739 |
|
|
2022
Q3 | $1.84M | Hold |
93,500
| – | – | ﹤0.01% | 1931 |
|
|
2022
Q2 | $1.64M | Buy |
+93,500
| New | +$1.47M | ﹤0.01% | 2059 |
|
|
2019
Q4 | – | Sell |
-17,800
| Closed | -$94K | – | 2549 |
|
|
2019
Q3 | $94K | Hold |
17,800
| – | – | ﹤0.01% | 2518 |
|
|
2019
Q2 | $137K | Buy |
17,800
+3,140
| +21% | +$47.8K | ﹤0.01% | 2553 |
|
|
2019
Q1 | $292K | Hold |
14,660
| – | – | ﹤0.01% | 2464 |
|
|
2018
Q4 | $194K | Hold |
14,660
| – | – | ﹤0.01% | 2518 |
|
|
2018
Q3 | $539K | Hold |
14,660
| – | – | ﹤0.01% | 2391 |
|
|
2018
Q2 | $513K | Buy |
14,660
+3,160
| +27% | +$121K | ﹤0.01% | 2434 |
|
|
2018
Q1 | $535K | Buy |
11,500
+1,440
| +14% | +$52.7K | ﹤0.01% | 2353 |
|
|
2017
Q4 | $377K | Hold |
10,060
| – | – | ﹤0.01% | 2463 |
|
|
2017
Q3 | $536K | Hold |
10,060
| – | – | ﹤0.01% | 2358 |
|
|
2017
Q2 | $573K | Buy |
10,060
+2,360
| +31% | +$118K | ﹤0.01% | 2364 |
|
|
2017
Q1 | $414K | Hold |
7,700
| – | – | ﹤0.01% | 2425 |
|
|
2016
Q4 | $439K | Hold |
7,700
| – | – | ﹤0.01% | 2434 |
|
|
2016
Q3 | $479K | Hold |
7,700
| – | – | ﹤0.01% | 2370 |
|
|
2016
Q2 | $435K | Hold |
7,700
| – | – | ﹤0.01% | 2420 |
|
|
2016
Q1 | $477K | Buy |
7,700
+1,340
| +21% | +$108K | ﹤0.01% | 2331 |
|
|
2015
Q4 | $895K | Buy |
+6,360
| New | +$864K | ﹤0.01% | 1900 |
|
Swiss National Bank's KDNY Position: Q3 2023 in Review
Swiss National Bank sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 100,300 shares — an estimated $3.85M sold.
Swiss National Bank first reported a position in KDNY in Q4 2015 and held it in 21 quarters. The position peaked at $3.85M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- Swiss National Bank reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Swiss National Bank sold 100,300 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $3.85M.
- Swiss National Bank first reported a position in Chinook Therapeutics, Inc. Common Stock in Q4 2015 and held it in 21 quarters.
- Swiss National Bank's Chinook Therapeutics, Inc. Common Stock position peaked at $3.85M in Q2 2023.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Swiss National Bank's 13F filing for Q3 2023, filed 8 Nov 2023.